(Q43947946)

28 November 2017

0 references

Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials (English)

1 reference

28 November 2017

1 reference

1 reference

1 reference

Cornu C

1

1 reference

28 November 2017

Yzèbe D

2

1 reference

28 November 2017

Léophonte P

3

1 reference

28 November 2017

Gaillat J

4

1 reference

28 November 2017

Boissel JP

5

1 reference

28 November 2017

Cucherat M

6

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

28 November 2017

11

1 reference

inferred from page(s)

published in

Vaccine

1 reference

28 November 2017

19

1 reference

28 November 2017

4780-4790

1 reference

28 November 2017

32

1 reference

Pneumococcal bacteremia in adults: a 14-year experience in an inner-city university hospital

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900217-1

7 January 2021

Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900217-1

7 January 2021

Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900217-1

7 January 2021

Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900217-1

7 January 2021

Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900217-1

7 January 2021

Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900217-1

7 January 2021

EasyMA: a program for the meta-analysis of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900217-1

7 January 2021

23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900217-1

7 January 2021

Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900217-1

7 January 2021

Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900217-1

7 January 2021

Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900217-1

7 January 2021

Placebo controlled pneumococcal immunization in patients with bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900217-1

7 January 2021

Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900217-1

7 January 2021

Community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900217-1

7 January 2021

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900217-1

7 January 2021

10.1016/S0264-410X(01)00217-1

Identifiers

DOI

1 reference

28 November 2017

1 reference